Immunity against the GBV-B hepatitis virus in tamarins can prevent productive infection following rechallenge and is long-lived

Journal of Medical Virology

Volumn 80, Issue 1, 2008, Pages 87-94

  Bukh, Jens ^a,b,c,e   Engle, Ronald E ^a   Govindarajan, Sugantha ^d   Purcell, Robert H ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^b Mental Health Center Glostrup   (Denmark)

^c UNIVERSITY OF COPENHAGEN   (Denmark)

^d RANCHO LOS AMIGOS NATIONAL REHABILITATION CENTER   (United States)

^e NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Hepatitis C virus; Protective immunity; Surrogate model

Indexed keywords

POLYPROTEIN;

ACUTE HEPATITIS; AMINO ACID SEQUENCE; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CONVALESCENCE; HEPATITIS C; HEPATITIS GB VIRUS A; HEPATITIS GB VIRUS B; IMMUNITY; INFECTION CONTROL; MOLECULAR CLONING; NONHUMAN; VIREMIA; VIRUS GENOME; VIRUS INFECTIVITY; VIRUS NEUTRALIZATION;

ANIMALS; FLAVIVIRIDAE INFECTIONS; GB VIRUS B; HEPACIVIRUS; HEPATITIS, VIRAL, ANIMAL; MONKEY DISEASES; POLYPROTEINS; RNA, VIRAL; SAGUINUS; VIREMIA;

ANIMALIA; GB VIRUS A; HEPATITIS C VIRUS; HEPATITIS GB VIRUS B; SAGUINUS IMPERATOR;

EID: 36849040702     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.21013     Document Type: Article

References (25)

1. Bartosch B, Bukh J, Meunier JC, Granier C, Engle RE, Blackwelder WC, Emerson SU, Cosset FL, Purcell RH. 2003. In vitro assay for neutralizing antibody to hepatitis C virus: Evidence for broadly conserved neutralization epitopes. Proc Natl Acad Sci USA 100:14199-14204.
2. Bassett SE, Guerra B, Brasky K, Miskovsky E, Houghton M, Klimpel GR, Lanford RE. 2001. Protective immune response to hepatitis C virus in chimpanzees rechallenged following clearance of primary infection. Hepatology 33:1479-1487.
3. Beames B, Chavez D, Guerra B, Notvall L, Brasky KM, Lanford RE. 2000. Development of a primary tamarin hepatocyte culture system for GB virus-B: A surrogate model for hepatitis C virus. J Virol 74:11764-11772.
4. Bukh J, Apgar CL. 1997. Five new or recently discovered (GBV-A) virus species are indigenous to New World monkeys and may constitute a separate genus of the Flaviviridae. Virology 229:429-436.
5. Bukh J, Apgar CL, Purcell RH. 1997. Natural history of GBV-A and GBV-B in primate models: Discovery of indigenous Flaviviridae-like viruses in several species of New World monkeys. In: Rizzetto M, Purcell RH, Gerin J, Verme G, editors. Viral Hepatitis and Liver Disease. Turin, Italy: Edizione Minerva Medica. pp 392-395.
6. Bukh J, Apgar CL, Engle R, Govindarajan S, Hegerich PA, Tellier R, Wong DC, Elkins R, Kew MC. 1998. Experimental infection of chimpanzees with hepatitis C virus of genotype 5a: Genetic analysis of the virus and generation of a standardized challenge pool. J Infect Dis 178:1193-1197.
7. Bukh J, Apgar CL, Yanagi M. 1999. Toward a surrogate model for hepatitis C virus: An infectious molecular clone of the GB virus-B hepatitis agent. Virology 262:470-478.
8. Bukh J, Apgar CL, Govindarajan S, Purcell RH. 2001. Host range studies of GB virus-B hepatitis agent, the closest relative of hepatitis C virus, in New World monkeys and chimpanzees. J Med Virol 65:694-697.
9. Bukh J, Thimme R, Govindarajan S, Forns X, Satterfield W, Eder E, Chang K-M, Yanagi M, Emerson SU, Chisari FV, Purcell RH. 2002. Monoclonal hepatitis C virus infection in chimpanzees. In: Margolis HS, Alter MJ, Liang TJ, Dienstag JL, editors. Viral Hepatitis and Liver Disease. Atlanta: International Medical Press, pp 336-340.
10. Burton DR. 2002. Antibodies, viruses and vaccines. Nat Rev Immunol 2:706-713.
11. Farci P, Alter HJ, Wong DC, Miller RH, Govindarajan S, Engle R, Shapiro M, Purcell RH. 1994. Prevention of hepatitis C virus infection in chimpanzees after antibody-mediated in vitro neutralization. Proc Natl Acad Sci USA 91:7792-7796.
12. Farci P, Shimoda A, Wong D, Cabezon T, De Gioannis D, Strazzera A, Shimizu Y, Shapiro M, Alter HJ, Purcell RH. 1996. Prevention of hepatitis C virus infection in chimpanzees by hyperimmune serum against the hypervariable region 1 of the envelope 2 protein. Proc Natl Acad Sci USA 93:15394-15399.
13. Haqshenas G, Dong X, Netter H, Torresi J, Gowans EJ. 2007. A chimeric GB virus B encoding the hepatitis C virus hypervariable region 1 is infectious in vivo. J Gen Virol 88:895-902.
14. Houghton M. 1996. Hepatitis C viruses. In: Fields BN, Knipe DM, Howley PM, editors. Fields Virology, 3rd edition. Philadelphia: Lippincott Raven. pp 1035-1058.
15. Leary TP, Desai SM, Yamaguchi J, Chalmers ML, Schlauder GG, Dawson GJ, Mushahwar IK. 1996. Species-specific variants of GB virus A in captive monkeys. J Virol 70:9028-9030.
16. Letvin NL, Barouch DH, Montefiori DC. 2002. Prospects for vaccine protection against hiv-1 infection and AIDS. Annu Rev Immunol 20:73-99.
17. Major ME, Mihalik K, Puig M, Rehermann B, Nascimbeni M, Rice CM, Feinstone SM. 2002. Previously infected and recovered chimpanzees exhibit rapid responses that control hepatitis C virus replication upon rechallenge. J Virol 76:6586-6595.
18. Martin A, Bodola F, Sangar DV, Goettge K, Popov V, Rijnbrand R, Lanford RE, Lemon SM. 2003. Chronic hepatitis associated with GB virus B persistence in a tamarin after intrahepatic inoculation of synthetic viral RNA. Proc Natl Acad Sci USA 100:9962-9967.
19. Muerhoff AS, Leary TP, Simons JN, Pilot-Matias TJ, Dawson GJ, Erker JC, Chalmers ML, Schlauder GG, Desai SM, Mushahwar IK. 1995. Genomic organization of GB viruses A and B: Two new members of the Flaviviridae associated with GB agent hepatitis. J Virol 69:5621-5630.
20. Nam JH, Faulk K, Engle RE, Govindarajan S, St Claire M, Bukh J. 2004. In vivo analysis of the 3′ untranslated region of GB virus B after in vitro mutagenesis of an infectious cDNA clone: Persistent infection in a transfected tamarin. J Virol 78:9389-9399.
21. Robertson B, Myers G, Howard C, Brettin T, Bukh J, Gaschen B, Gojobori T, Maertens G, Mizokami M, Nainan O, Netesov S, Nishioka K, Shin i T, Simmonds P, Smith D, Stuyver L, Weiner A. 1998. Classification, nomenclature, and database development for hepatitis C virus (HCV) and related viruses: Proposals for standardization. International Committee on Virus Taxonomy. Arch Virol 143:2493-2503.
22. Sbardellati A, Scarselli E, Verschoor E, De Tomassi A, Lazzaro D, Traboni C. 2001. Generation of infectious and transmissible virions from a GB virus B full-length consensus clone in tamarins. J Gen Virol 82:2437-2448.
23. Schlauder GG, Dawson GJ, Simons JN, Pilot-Matias TJ, Gutierrez RA, Heynen CA, Knigge MF, Kurpiewski GS, Buijk SL, Leary TP, Van Sant CL, Mushahwar IK. 1995. Molecular and serologic analysis in the transmission of the GB hepatitis agents. J Med Virol 46:81-90.
24. Schmidt NJ, Emmons RW. 1989. General Priciples of laboratory diagnostic methods for viral, richettsial and chlamydial infections: Computation of 50 percent endpoints. In: Schmidt NJ, Emmons RW, editors. Diagnostic proceedures for viral, richettsial and chlamydial infections. Washington, DC: American Public Health Association. pp 32-35.
25. Simons JN, Pilot-Matias TJ, Leary TP, Dawson GJ, Desai SM, Schlauder GG, Muerhoff AS, Erker JC, Buijk SL, Chalmers ML, Muerhoff AS, Desai SM, Mushahwar IK. 1995. Identification of two fiavivirus-like genomes in the GB hepatitis agent. Proc Natl Acad Sci USA 92:3401-3405.